Skip to content

Clinical trials

Phase 1 Overweight trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Phase 1 Status: Unknown status Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20091
20131
20161
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayside Health1
Cambridge University Hospitals NHS Foundation Trust1
Central FITT, Inc1
Empros Pharma AB1
Landspitali University Hospital1
National Heart, Lung, and Blood Institute (NHLBI)1
Piramal Enterprises Limited1
Seoul National University Hospital1
Universidad de Guanajuato1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight9
Obesity4
Insulin Resistance3
Bone Resorption1
Diabetes Mellitus, Type 11
Diabetes Mellitus, Type 21
Diabetes, Gestational1
Heart Failure1
Hypertension, Pregnancy-Induced1
Metabolic Syndrome1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.